- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.02. | APPYEA, INC - 8-K, Current Report | 5 | SEC Filings | ||
| 20.01. | AppYea Inc.: AppYea's CFO Ron Mekler Makes $225,000 Strategic Equity Investment, Reinforcing Executive Alignment Following Asset Closing | 131 | PR Newswire | The investment by the Company's Chief Financial Officer reflects direct management alignment as AppYea advances efforts towards commercial deployment.
JERUSALEM... ► Artikel lesen | |
| 13.01. | AppYea beruft Techlott-Gründer zum President und treibt Blockchain-Expansion voran | 2 | Investing.com Deutsch | ||
| 13.01. | AppYea appoints Techlott founder as president in blockchain push | 4 | Investing.com | ||
| 13.01. | AppYea: Ben Harris Named As CTO And Director | 1 | pulse2.com | ||
| APPYEA Aktie jetzt für 0€ handeln | |||||
| 12.01. | AppYea appoints Ben Harris as CTO and board director | 1 | Investing.com | ||
| 12.01. | AppYea Inc.: AppYea Appoints Ben Harris as Chief Technology Officer and Director; Provides Technology Execution Update | 137 | PR Newswire | JERUSALEM, Jan. 12, 2026 /PRNewswire/ -- AppYea, Inc. (OTCQB: APYP) ("AppYea" or the "Company"), a provider of blockchain-based trust infrastructure for regulated... ► Artikel lesen | |
| 07.01. | APPYEA, INC - 8-K, Current Report | - | SEC Filings | ||
| 19.11.25 | APPYEA, INC - 10-Q, Quarterly Report | - | SEC Filings | ||
| 18.11.25 | AppYea Inc.: AppYea Accelerates Strategic Transformation: Internal Management Review as to Uplisting to a National Exchange, Rebranding to Mellatrix, Closing and Completion of Techlott Integration -- Including Evaluation ... | 392 | PR Newswire | JERUSALEM, Nov. 18, 2025 /PRNewswire/ -- AppYea, Inc. (OTCQB: APYP) today announced the acceleration of its strategic internal management review toward a potential... ► Artikel lesen | |
| 15.10.25 | APPYEA, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 03.10.25 | APPYEA, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 21.08.25 | APPYEA, Inc.: AppYea Inc. Acquires Techlott's Institutional-Grade Blockchain Lottery & Gaming Platform in Strategic Business Pivot | 322 | ACCESS Newswire | JERUSALEM, IL / ACCESS Newswire / August 21, 2025 / AppYea Inc. (OTCQB:APYP) today announced a strategic business pivot with the acquisition of Techlott Ltd.'s proprietary blockchain-based lottery and... ► Artikel lesen | |
| 14.08.25 | APPYEA, Inc.: Yakir Abadi, Recognized Fintech and Blockchain Leader, Joins AppYea as CEO | 323 | ACCESS Newswire | JERUSALEM, IL / ACCESS Newswire / August 14, 2025 / AppYea Inc. (OTCQB:APYP) today announced the appointment of Yakir Abadi as Chief Executive Officer and director and Eldar Edmond Grady as Executive... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 18,860 | -1,77 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,150 | -1,27 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 47,530 | -1,35 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Falko Friedrichs lobte in seiner am Donnerstag vorliegenden... ► Artikel lesen | |
| PROGYNY | 17,800 | +1,60 % | INVO Fertility, Inc.: INVO Fertility's Wisconsin Clinic Joins Progyny Network | ||
| FRESENIUS MEDICAL CARE | 39,240 | +0,23 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 47,50 auf 46,50 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Das Wachstum der Behandlungszahlen... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,600 | +2,62 % | Truist cuts Procept BioRobotics stock price target on lower forecasts | ||
| LIFESTANCE HEALTH GROUP | 7,325 | +2,45 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 23,910 | +2,44 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| INNOVAGE | 10,610 | +14,46 % | InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025 | DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| NEUROPACE | 13,960 | -1,34 % | Why NeuroPace Stock Was Inching Higher on Wednesday | ||
| PRIVIA HEALTH GROUP | 24,310 | +1,21 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| BETA BIONICS | 11,380 | -6,80 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| TALKSPACE | 4,930 | +1,75 % | Talkspace Announces Fourth Quarter and Full Year 2025 Results | 4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | +0,36 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| CARL ZEISS MEDITEC | 25,640 | -0,93 % | INDEX-MONITOR: Lufthansa verpasst Dax-Rückkehr - Nur Wechsel in MDax und SDax | ZUG (dpa-AFX) - Die Aktien von Lufthansa haben die Rückkehr in den deutschen Leitindex Dax verpasst. Wie der zur Deutschen Börse gehörende Index-Anbieter Stoxx am späten Mittwochabend mitteilte, bleibt... ► Artikel lesen |
APPYEA INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu APPYEA INC finden Sie auf Wallstreet Online.